GOV.UK
Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Drug Analysis Prints (DAPs)
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance and publications about a possible no-deal Brexit
Information about the regulation of medicines and medical devices if there is a no-deal Brexit.
News story
Welcome new MHRA senior appointments
The Medicines and Healthcare products Regulatory Agency (MHRA) is welcoming two directors.
Press release
Emerade pens – patients reminded to carry 2 pens at all times
Patients who carry Emerade auto-injector pens for the emergency treatment of severe acute allergic reactions (anaphylaxis) to foods, medicines or insect stings are being reminded of existing advice to carry 2, in-date pens with them - at all times.
Press release
Ranitidine – MHRA drug alert issued for Teva UK recall
Teva UK Ltd is recalling unexpired stock of certain batches of 2 types of Ranitidine medicines used to treat conditions such as heartburn and stomach ulcers.
Press release
MHRA and the Bill & Melinda Gates Foundation to look at the safer, effective use of medicines during pregnancy
MHRA and the Bill & Melinda Gates Foundation have begun new research on medicine use which could impact the health of pregnant women around the world.
Press release
HRT users to discuss risks and benefits at next appointment as new study highlights persistent risk of breast cancer
Women who are current or past users of hormone replacement therapy (HRT) to treat symptoms of the menopause are reminded to be vigilant for signs of breast cancer, even after stopping HRT.
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Services
See all servicesPolicy papers and consultations
- MHRA consultation on EU exit no-deal legislative proposals
- How should we engage and involve patients and the public in our work
Transparency and freedom of information releases
- Medicines and Healthcare products Regulatory Agency Privacy Notice
- Clinical trials for medicines: authorisation assessment performance
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts